Together, our results demonstrate that alterations in BMP correlate with reduced GlcCer catabolism in CSF from LRRK2-PD patients and suggest that LRRK2-dependent effects on GCase activity may drive BMP alterations in disease. Here, LRRK2 is linked to Parkinson disease.